Don't wanna be here? Send us removal request.
Statistics
We looked inside some of the posts by integrimedical and here's what we found interesting.
Average Info
Notes Per Post
0
Likes Per Post
0
Reblog Per Post
0
Reply Per Post
0
Time Between Posts
6 days
Number of Posts By Type
Text
17
Last Seen Tumblr Blogs
Fun Fact
Total funding amounts to $125.3M.
Text
Serum Institute picks up 20% in needle-free tech company IntegriMedical
Vaccine major Serum Institute of India has acquired 20 per cent stake in medical device company IntegriMedical to advance needle-free injection technology, for an undisclosed amount.
The technology addresses needle-phobic patients, helping increase patient compliance, reduce needle-stick injuries, and enhancing the efficacy of liquid medication via needle-free dispersion, a note from the company said.
Serum Institute of India (SII) has been investing in backend companies and had in August 2021, bought out the Indian partner in SCHOTT Kaisha, securing its supplies of pharma packaging products, including vials, syringes, ampoules and cartridges used to package life-saving medication.
IntegriMedical has developed a US patented needle-free injection system (N-FIS) that utilises high-velocity jet stream using mechanical power to effectively and consistently administer biologics and drugs, the note said. N-FIS will be available in the Indian private market, offering patients and healthcare providers an alternative to traditional needle-based injections, it added, without giving timelines.
Adar Poonawalla, SII Chief Executive said, they were constantly seeking opportunities to invest in technologies that aligned with its mission. “IntegriMedical’s Needle-Free Injection Systems represent a significant advancement in drug delivery and we envision a needle-free solution to deliver vaccines,” he said, adding that it would “potentially revolutionize the way we administer vaccines”.
Read more@ https://www.thehindubusinessline.com/companies/serum-institute-picks-up-20-in-needle-free-tech-company-integrimedical/article68185400.ece
0 notes
Text
Serum Institute of India Invests in IntegriMedical
Serum Institute of India (SII) has announced a strategic investment in IntegriMedical, acquiring a 20% stake in the company, to advance Needle-Free Injection System technology.
The partnership between SII and IntegriMedical aligns with SII's vision of 'Health for All' and IntegriMedical's mission to ‘Transform Healthcare Globally’ by providing patient comfort, ensuring increased patient compliance, reducing needle-stick injuries, and enhancing the efficacy of liquid medication via needle-free dispersion.
IntegriMedical has developed a US patented Needle-Free Injection System (N-FIS) that utilises high-velocity jet stream using mechanical power to effectively and consistently administer biologics and drugs. The innovative drug delivery solution aims to alleviate pain during administration, providing needle-phobic patients with a pleasant and stress-free experience.
Read more@ https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/pharma-finance-and-investment-news/serum-institute-of-india-invests-in-integrimedical/
0 notes
Text
SII invests in IntegriMedical’s Needle-Free Injection System technology
With this investment, SII will acquire a 20 per cent stake in IntegriMedical. Reportedly, the investment is expected to accelerate the development and commercialisation of the N-FIS technology
Serum Institute of India (SII), has announced an investment in IntegriMedical, acquiring a 20 per cent stake in the company, to advance Needle-Free Injection System technology.
IntegriMedical has developed a US patented Needle-Free Injection System (N-FIS) that utilises high-velocity jet stream using mechanical power to effectively and consistently administer biologics and drugs. The innovative drug delivery solution aims to alleviate pain during administration, providing needle-phobic patients with a pleasant and stress-free experience. IntegriMedical’s N-FIS has received regulatory approvals from CDSCO, CE, MDSAP and is ISO 13485 certified.
Read more@ https://www.expresspharma.in/sii-invests-in-integrimedicals-needle-free-injection-system-technology/
0 notes
Text
India’s Serum Institute Invests in IntegriMedical of Indiana
Pune-based Serum Institute of India (SII) announced a strategic investment in IntegriMedical, based in Bainbridge, IN. where SII will acquire a 20% stake in the company. This partnership aims to advance IntegriMedical’s Needle-Free Injection System (N-FIS) technology, aligning with SII’s vision of ‘Health for All’ and IntegriMedical’s mission to ‘Transform Healthcare Globally.”
N-FIS utilizes a high-velocity jet stream powered by mechanical force to effectively and consistently administer biologics and liquid medications without needles. This needle-free drug delivery solution seeks to alleviate pain during administration, providing needle-phobic patients with a more pleasant and stress-free experience while enhancing medication efficacy through needle-free dispersion.
Read more@ https://amritt.com/the-india-expert-blog/indias-serum-institute-invests-in-integrimedical-of-indiana/
0 notes
Text
https://www.business-standard.com/companies/news/sii-to-acquire-20-stake-in-needle-free-tech-company-integrimedical-124051701190_1.html
SII to acquire 20% stake in needle-free tech company IntegriMedical
Vaccine manufacturer Serum Institute of India (SII) announced an investment in IntegriMedical, a medical technology company developing needle-free injection systems (N-FIS). This collaboration aims to advance N-FIS technology and make it more accessible to patients globally.
SII will acquire a 20 per cent stake in IntegriMedical. This investment is expected to accelerate the development and commercialisation of N-FIS, offering a more comfortable and painless vaccination experience. N-FIS technology uses a high-velocity jet stream to administer medications, eliminating needle phobia and needle-stick injuries. This aligns with SII's mission of "Health for All" and IntegriMedical's goal to "Transform Healthcare Globally."
Read more@ https://www.business-standard.com/companies/news/sii-to-acquire-20-stake-in-needle-free-tech-company-integrimedical-124051701190_1.html
0 notes
Text
Serum-backed IntegriMedical's needle-free injection picks up pace
Are you scared of needles and dread going for a vaccine or shot? Whether it's for your children or yourself, the fear is common!
The Needle-Free Injection System is gaining traction in the country.
According to IntegriMedical, a healthcare solutions company that claims to have developed India's first Needle-Free Injection System (N-FIS), the increase in sales since its launch indicates that healthcare professionals are recommending or switching to needle-free systems to accommodate children and needle-phobic patients.
IntegriMedical received CDSCO approval for N-FIS in December 2022 and formally launched it in the retail market in April 2024, following initial piloting in 2023.
Sarvesh Mutha, MD of IntegriMedical, told CNBC-TV18 that since the launch, “sales have been substantially growing, with over 500 doctors administering more than 35,000 injections in India, along with initiating sales activities in Europe.”
Read more@ https://www.cnbctv18.com/india/healthcare/serum-backed-integrimedicals-needle-free-injection-picks-up-pace-19485059.htm
0 notes
Text
https://amritt.com/the-india-expert-blog/indias-serum-institute-invests-in-integrimedical-of-indiana/
India’s Serum Institute Invests in IntegriMedical of Indiana
Pune-based Serum Institute of India (SII) announced a strategic investment in IntegriMedical, based in Bainbridge, IN. where SII will acquire a 20% stake in the company. This partnership aims to advance IntegriMedical’s Needle-Free Injection System (N-FIS) technology, aligning with SII’s vision of ‘Health for All’ and IntegriMedical’s mission to ‘Transform Healthcare Globally.”
N-FIS utilizes a high-velocity jet stream powered by mechanical force to effectively and consistently administer biologics and liquid medications without needles. This needle-free drug delivery solution seeks to alleviate pain during administration, providing needle-phobic patients with a more pleasant and stress-free experience while enhancing medication efficacy through needle-free dispersion.
Read more@ https://amritt.com/the-india-expert-blog/indias-serum-institute-invests-in-integrimedical-of-indiana/
0 notes
Text
SII will buy 20 percent stake in Integrimedical
New Delhi, Vaccine maker Serum Institute of India (SII) on Friday said it is acquiring 20 per cent stake in Integrimedical to advance needle-free injection system technology. IntegriMedical has developed a US-patented needle-free injection system (N-FIS) that uses mechanical power to effectively administer biologics and drugs through high-speed injection, Serum Institute of India (SII) said in a statement. Velocity uses the jet stream. However, the company did not disclose financial details of the transaction. The innovative drug delivery solution aims to minimize pain during administration, providing a stress-free experience to needle-phobic patients. “IntegriMedical's N-FIS represents a significant advancement in drug delivery and we envision a needle-free solution for delivering vaccines. We believe this could potentially revolutionize the way we administer vaccines, making the process more comfortable for patients and health care professionals,” said SII CE Adar Poonawala. IntegriMedical's N-FIS has received regulatory approvals from CDSCO (Centra Drugs Standard Control Organisation), CE (European Regulatory Approvals), MDSA (Medical Device Single Audit Programme, Australia) and is ISO 13485 certified, the statement said. Read more@ https://www.theindiancommunity.org/news/sii-will-buy-20-percent-stake-in-integrimedical.40728/
0 notes
Text
Startup Mantra: Needle-free injection tech boost
IntegriMedical has launched India's first Needle-Free Injection System to ease the pain of injections for children and adults, enhancing healthcare experiences.
Check into any pediatrician’s clinic and chances are you will hear little kids bawling. They’d be fine even during the doctor’s examination but the moment the injection is in the doctor’s hand the crying begins. And while this tears a young mother’s heart to see her baby cry, she understands that this is one ‘pain’ her child must endure and learn to accept. And if truth be told there are many adults too who fear the needle. So, what could be done?
Says Sarvesh Mutha, co-founder and managing director of IntegriMedical, “We looked at the problem deep and hard and felt that things should change. Injections should not be painful, not even for a nanosecond. That is when IntegriMedical developed the Needle Free Injection System (NFIS) in April 2024.”
Read more@ https://www.hindustantimes.com/cities/pune-news/startup-mantra-needle-free-injection-tech-boost-101728677635592.html
0 notes
Text
Serum-backed IntegriMedical's needle-free injection picks up pace
Are you scared of needles and dread going for a vaccine or shot? Whether it's for your children or yourself, the fear is common!
The Needle-Free Injection System is gaining traction in the country.
According to IntegriMedical, a healthcare solutions company that claims to have developed India's first Needle-Free Injection System (N-FIS), the increase in sales since its launch indicates that healthcare professionals are recommending or switching to needle-free systems to accommodate children and needle-phobic patients.
IntegriMedical received CDSCO approval for N-FIS in December 2022 and formally launched it in the retail market in April 2024, following initial piloting in 2023.
Sarvesh Mutha, MD of IntegriMedical, told CNBC-TV18 that since the launch, “sales have been substantially growing, with over 500 doctors administering more than 35,000 injections in India, along with initiating sales activities in Europe.”
Read more@ https://www.cnbctv18.com/india/healthcare/serum-backed-integrimedicals-needle-free-injection-picks-up-pace-19485059.htm
0 notes
Text
https://hiindia.com/sii-invests-in-integrimedical-to-advance-indias-1st-needle-free-tech-20240517103607-11/
SII invests in IntegriMedical to advance India’s 1st needle-free tech
Pune, May 17 (IANS) Serum Institute of India (SII), the world’s largest vaccine manufacturer, on Friday announced a strategic investment in IntegriMedical to advance Needle-Free Injection System (N-FIS) technology.
With the investment, SII will acquire a 20 per cent stake in IntegriMedical. The investment will also accelerate the development and commercialisation of the N-FIS technology, making it more widely accessible to patients in India and worldwide“At SII, we are constantly seeking opportunities to invest in technologies that align with our mission to make healthcare accessible and affordable for people worldwide.
Read more@ https://hiindia.com/sii-invests-in-integrimedical-to-advance-indias-1st-needle-free-tech-20240517103607-11/
0 notes
Text
https://hiindia.com/sii-invests-in-integrimedical-to-advance-indias-1st-needle-free-tech-20240517103607-11/
SII invests in IntegriMedical to advance India’s 1st needle-free tech
Pune, May 17 (IANS) Serum Institute of India (SII), the world’s largest vaccine manufacturer, on Friday announced a strategic investment in IntegriMedical to advance Needle-Free Injection System (N-FIS) technology.
With the investment, SII will acquire a 20 per cent stake in IntegriMedical. The investment will also accelerate the development and commercialisation of the N-FIS technology, making it more widely accessible to patients in India and worldwide“At SII, we are constantly seeking opportunities to invest in technologies that align with our mission to make healthcare accessible and affordable for people worldwide.
Read more@ https://hiindia.com/sii-invests-in-integrimedical-to-advance-indias-1st-needle-free-tech-20240517103607-11/
0 notes
Text
best corporate law firms in pune
Rishabh Gandhi and Advocates is among the Top 10 Corporate Law Firms in Pune and has a team of highly qualified advocates who have made the Firm one of the top law firms in Pune. The firm is also featured in 10 Most Promising Corporate Legal Consultants of India by Silicon India Magazine in 2018. RGAA strives to fulfill the needs of the client efficiently and economically and has a bright past as a Corporate Law firm in Pune. Rishabh Gandhi and Advocates handles all the corporatematters ranging from Dispute Resolution to Commercial Drafting. For more details you can write to [email protected] or call on +91 9075281109 or visit here https://www.rgaa.co.in/
0 notes
Text
https://www.rgaa.co.in/best-real-estate-property-lawyers-advocate-law-firms-in-mumbai-maharashtra-india/
property advocate in mumbai
Rishabh Gandhi and Advocates are dealing with property matters which has always been a complex process. RGAA’s founder, Rishabh Gandhi is a former judge and his team of property lawyers in mumbai has dealt with all kinds of property cases successfully each time. Firm expertise has always achieved the goals of the client in the best possible way. The Firm’s diverse interest in Property Laws has always offered the clients with utter success and satisfaction. The firm dedicates its time and efforts to fulfill the needs of the clients. RGAA has its outstanding ability to analyze every possible scenario and achieving the best possible result for its client.For more details you can write to [email protected] or call on +91 9075281109 or visit here http://rgaa.co.in/
0 notes
Text
Trademark lawyers in Pune
Trademark is a visual symbol, which a business uses to distinguish its goods and services. It can be registered by the Controller General of Patents Designs and Trademarks, Ministry of Commerce, Government of India. In case of copyright or infringement issues, Rishabh Gandhi and Advocates who is among the best trademark lawyers in Pune helps in solving the issues and giving the right solution to the clients. RGAA offers one of the best services in Pune including trademark infringement suits, Intellectual Property Rights and Copyright issues. RGAA also helps the clients in trademark registration and provides copyrights lawyers in Pune. For more details you can write to [email protected] or call on +91 9075281109 or visit here https://www.rgaa.co.in/
Read more@ https://www.rgaa.co.in/trademark-lawyers-in-pune/
0 notes
Text
legal advice for startups india
Registering a corporate or a limited liability partnership provides a form of business that can be easily maintained and it also helps owners by providing them with limited liability. A brief consultation with Company Registration Lawyers or LLP registration lawyers is very beneficial and prevents the clients to make silly mistakes and reduce the time consumed for following every process in it. Rishabh Gandhi and Advocates gives advice to the corporate clients for starts-ups and company incorporation or LLP. The Firm has advised many insurance companies, individuals, and businessmen, with success in recovering a huge amount of money, stuck in complex legal disputes. For more details you can write to [email protected] or call on +91 9075281109 or visit here https://www.rgaa.co.in/
Read more@ https://www.rgaa.co.in/legal-advice-for-startups-india/
0 notes
Text
Serum Institute picks up 20% in needle-free tech company IntegriMedical
Vaccine major Serum Institute of India has acquired 20 per cent stake in medical device company IntegriMedical to advance needle-free injection technology, for an undisclosed amount.
The technology addresses needle-phobic patients, helping increase patient compliance, reduce needle-stick injuries, and enhancing the efficacy of liquid medication via needle-free dispersion, a note from the company said.
Serum Institute of India (SII) has been investing in backend companies and had in August 2021, bought out the Indian partner in SCHOTT Kaisha, securing its supplies of pharma packaging products, including vials, syringes, ampoules and cartridges used to package life-saving medication.
IntegriMedical has developed a US patented needle-free injection system (N-FIS) that utilises high-velocity jet stream using mechanical power to effectively and consistently administer biologics and drugs, the note said. N-FIS will be available in the Indian private market, offering patients and healthcare providers an alternative to traditional needle-based injections, it added, without giving timelines.
Adar Poonawalla, SII Chief Executive said, they were constantly seeking opportunities to invest in technologies that aligned with its mission. “IntegriMedical’s Needle-Free Injection Systems represent a significant advancement in drug delivery and we envision a needle-free solution to deliver vaccines,” he said, adding that it would “potentially revolutionize the way we administer vaccines”.
Read more@ https://www.thehindubusinessline.com/companies/serum-institute-picks-up-20-in-needle-free-tech-company-integrimedical/article68185400.ece
0 notes